A significant advance in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer suppressor protein is frequently inactivated in several forms of cancer, resulting https://ztndz.com/story29825964/vhh-fragments-restore-the-p53-protein-a-promising-approach-for-tumor-management